Freedman J, Hökfelt T, Jonsson G, Post C
Exp Brain Res. 1986;62(1):175-8. doi: 10.1007/BF00237413.
Intrathecal administration of the substance P antagonist Spantide caused marked necrotic changes of the gray matter of the spinal cord extending several segments from the injection site. Intravenous treatment with several doses of thyrotropin releasing hormone before and after Spantide injection completely prevented the necrotic lesion.
鞘内注射P物质拮抗剂Spantide可导致脊髓灰质出现明显的坏死性改变,坏死范围从注射部位延伸至数个节段。在注射Spantide之前和之后静脉注射几剂促甲状腺激素释放激素,可完全预防坏死性病变。